Subxiphoid thoracoscopic thymectomy for myasthenia gravis

The treatment options for myasthenia gravis (MG) include medication and thymectomy; thymectomy plus medication provides better remission of MG and reduced risk of recurrence compared with medication alone [1]. We investigated the efficacy of subxiphoid thoracoscopic thymectomy in patients with myasthenia gravis. The data of 37 consecutive cases were reviewed. 2 cases of postoperative myasthenia gravis crisis and 4 cases of residual mediastinal fat tissue were recorded. Moreover, 29 patients presented the neurological outcomes, and complete stable remission was achieved in 5 (17.2%) cases. Subxiphoid thymectomy is technically feasible. High-quality evidence is warranted before this approach can be recommended.